JPS58222020A - 前処置用下剤 - Google Patents
前処置用下剤Info
- Publication number
- JPS58222020A JPS58222020A JP10378282A JP10378282A JPS58222020A JP S58222020 A JPS58222020 A JP S58222020A JP 10378282 A JP10378282 A JP 10378282A JP 10378282 A JP10378282 A JP 10378282A JP S58222020 A JPS58222020 A JP S58222020A
- Authority
- JP
- Japan
- Prior art keywords
- colon
- pretreatment
- magnesium citrate
- purgative
- laxative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008141 laxative Substances 0.000 title claims abstract description 20
- 230000001543 purgative effect Effects 0.000 title abstract 4
- 229960005336 magnesium citrate Drugs 0.000 claims abstract description 19
- 235000002538 magnesium citrate Nutrition 0.000 claims abstract description 19
- 239000004337 magnesium citrate Substances 0.000 claims abstract description 19
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims abstract description 19
- 230000002475 laxative effect Effects 0.000 claims abstract description 14
- GOZDTZWAMGHLDY-UHFFFAOYSA-L sodium picosulfate Chemical compound [Na+].[Na+].C1=CC(OS(=O)(=O)[O-])=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS([O-])(=O)=O)C=C1 GOZDTZWAMGHLDY-UHFFFAOYSA-L 0.000 claims abstract description 12
- 229960005077 sodium picosulfate Drugs 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000006193 liquid solution Substances 0.000 claims description 2
- 238000012360 testing method Methods 0.000 abstract description 14
- 210000001072 colon Anatomy 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 229940081063 picosulfate sodium Drugs 0.000 abstract description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract description 2
- 206010028813 Nausea Diseases 0.000 abstract description 2
- 206010047700 Vomiting Diseases 0.000 abstract description 2
- 230000008693 nausea Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 230000008673 vomiting Effects 0.000 abstract description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 1
- 230000003187 abdominal effect Effects 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 229910052938 sodium sulfate Inorganic materials 0.000 abstract 1
- 235000011152 sodium sulphate Nutrition 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 9
- 210000000664 rectum Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 210000001815 ascending colon Anatomy 0.000 description 5
- 210000004534 cecum Anatomy 0.000 description 5
- 210000001731 descending colon Anatomy 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000001599 sigmoid colon Anatomy 0.000 description 5
- 238000012084 abdominal surgery Methods 0.000 description 4
- 210000003405 ileum Anatomy 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 206010022699 Intestinal stenosis Diseases 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000011231 Crohn disease Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000792859 Enema Species 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000007920 enema Substances 0.000 description 2
- 229940095399 enema Drugs 0.000 description 2
- 229940125722 laxative agent Drugs 0.000 description 2
- 208000014081 polyp of colon Diseases 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 210000003384 transverse colon Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- LJROKJGQSPMTKB-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)-pyridin-2-ylmethyl]phenol Chemical compound C1=CC(O)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(O)C=C1 LJROKJGQSPMTKB-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 208000019399 Colonic disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 201000010838 ascending colon cancer Diseases 0.000 description 1
- 229960000503 bisacodyl Drugs 0.000 description 1
- 238000002052 colonoscopy Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- -1 tricarboxylic acid magnesium salt Chemical class 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10378282A JPS58222020A (ja) | 1982-06-18 | 1982-06-18 | 前処置用下剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10378282A JPS58222020A (ja) | 1982-06-18 | 1982-06-18 | 前処置用下剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58222020A true JPS58222020A (ja) | 1983-12-23 |
| JPH0121811B2 JPH0121811B2 (enrdf_load_stackoverflow) | 1989-04-24 |
Family
ID=14362979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10378282A Granted JPS58222020A (ja) | 1982-06-18 | 1982-06-18 | 前処置用下剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58222020A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014502598A (ja) * | 2010-12-13 | 2014-02-03 | トーマス・ジュリアス・ボロディ | 胃および結腸製剤ならびにそれらを作製するための方法および使用するための方法 |
-
1982
- 1982-06-18 JP JP10378282A patent/JPS58222020A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014502598A (ja) * | 2010-12-13 | 2014-02-03 | トーマス・ジュリアス・ボロディ | 胃および結腸製剤ならびにそれらを作製するための方法および使用するための方法 |
| US10092573B2 (en) | 2010-12-13 | 2018-10-09 | Salix Pharmaceuticals, Inc. | Gastric and colonic formulations and methods for making and using them |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0121811B2 (enrdf_load_stackoverflow) | 1989-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9040095B2 (en) | Colon cleansing of residual stool and secretions during colonoscopy | |
| ES2655172T3 (es) | Procedimiento para preparación temporal de una colonoscopia en la que se administra una composición de picosulfato | |
| CN101938994A (zh) | 肠道催泻剂及其用途 | |
| JP2005530743A (ja) | 結腸の洗浄のための塩溶液 | |
| Channer et al. | Effect of posture and drink volume on the swallowing of capsules | |
| EP1976520B1 (en) | Kit comprising an osmotic laxative and a stimulant laxative for preparing the colon for virtual colonoscopy | |
| Iida et al. | Spontaneous disappearance of fundic gland polyposis: report of three cases | |
| WO2022055286A1 (ko) | 장 정결용 조성물 | |
| CN112089717B (zh) | 一种阿拉伯糖的用途和用于肠道准备的组合物 | |
| Sotaniemi et al. | Oral contraception and liver damage | |
| Lee et al. | Variables in the preparation of the large intestine for double contrast barium enema examination. | |
| WO2014185283A1 (ja) | 大腸の検査または手術のための処置剤および処置方法 | |
| Müller et al. | Randomized clinical trial comparing sodium picosulfate with mannitol on the preparation FOR colonoscopy in hospitalized patients | |
| JPS58222020A (ja) | 前処置用下剤 | |
| Jones et al. | The prevalence of gallbladder disease in patients with ileostomy | |
| CN112870382A (zh) | 阿拉伯糖和硅油类消泡剂联合用于肠道准备 | |
| JP2023549291A (ja) | 結腸洗浄のための硫酸塩製剤 | |
| Teague et al. | Preparation of the large bowel for endoscopy | |
| JP2015212230A (ja) | 大腸の検査または手術のための処置剤 | |
| CN112315972B (zh) | 一种用于肠道准备的组合物 | |
| Block | Management of constipation with a refined psyllium combined with dextrose | |
| JP2002053496A (ja) | Ｘ線造影剤の造影能改善剤ならびに腸管洗浄配合剤および腸管洗浄用キット | |
| Moraes | DOUBLE-BLIND PROSPECTIVE RANDOMIZED STUDY COMPARING POLYETHYLENE GLYCOL TO LACTULOSE FOR BOWEL PREPARATION IN COLONOSCOPY | |
| Hey et al. | Endoscopic evaluations of potentially ulcerogenic drugs: a new in vivo porcine test model | |
| Eke et al. | Bowel preparation in children and adolescents undergoing ileo-colonoscopy: what is new? |